Global and Japan Tourette Syndrome Drug Market Insights, Forecast to 2026
Table of Contents1 Study Coverage
1.1 Tourette Syndrome Drug Product Introduction
1.2 Market Segments
1.3 Key Tourette Syndrome Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Tourette Syndrome Drug Market Size Growth Rate by Type
1.4.2 AZD-5213
1.4.3 CPP-115
1.4.4 Dutetrabenazine ER
1.4.5 Ecopipam Hydrochloride
1.4.6 Others
1.5 Market by Application
1.5.1 Global Tourette Syndrome Drug Market Size Growth Rate by Application
1.5.2 Research Center
1.5.3 Hospital
1.5.4 Clinic
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Tourette Syndrome Drug Market Size, Estimates and Forecasts
2.1.1 Global Tourette Syndrome Drug Revenue 2015-2026
2.1.2 Global Tourette Syndrome Drug Sales 2015-2026
2.2 Global Tourette Syndrome Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Tourette Syndrome Drug Historical Market Size by Region (2015-2020)
2.3.1 Global Tourette Syndrome Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Tourette Syndrome Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Tourette Syndrome Drug Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Tourette Syndrome Drug Sales Forecast by Region (2021-2026)
2.4.2 Global Tourette Syndrome Drug Revenue Forecast by Region (2021-2026)
3 Global Tourette Syndrome Drug Competitor Landscape by Players
3.1 Global Top Tourette Syndrome Drug Sales by Manufacturers
3.1.1 Global Tourette Syndrome Drug Sales by Manufacturers (2015-2020)
3.1.2 Global Tourette Syndrome Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Global Tourette Syndrome Drug Manufacturers by Revenue
3.2.1 Global Tourette Syndrome Drug Revenue by Manufacturers (2015-2020)
3.2.2 Global Tourette Syndrome Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Tourette Syndrome Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Tourette Syndrome Drug Revenue in 2019
3.2.5 Global Tourette Syndrome Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Tourette Syndrome Drug Price by Manufacturers
3.4 Global Tourette Syndrome Drug Manufacturing Base Distribution, Product Types
3.4.1 Tourette Syndrome Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Tourette Syndrome Drug Product Type
3.4.3 Date of International Manufacturers Enter into Tourette Syndrome Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Tourette Syndrome Drug Market Size by Type (2015-2020)
4.1.1 Global Tourette Syndrome Drug Sales by Type (2015-2020)
4.1.2 Global Tourette Syndrome Drug Revenue by Type (2015-2020)
4.1.3 Tourette Syndrome Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Tourette Syndrome Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Tourette Syndrome Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Tourette Syndrome Drug Revenue Forecast by Type (2021-2026)
4.2.3 Tourette Syndrome Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Tourette Syndrome Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Tourette Syndrome Drug Market Size by Application (2015-2020)
5.1.1 Global Tourette Syndrome Drug Sales by Application (2015-2020)
5.1.2 Global Tourette Syndrome Drug Revenue by Application (2015-2020)
5.1.3 Tourette Syndrome Drug Price by Application (2015-2020)
5.2 Tourette Syndrome Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Tourette Syndrome Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Tourette Syndrome Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Tourette Syndrome Drug Price Forecast by Application (2021-2026)
6 Japan by Players, Type and Application
6.1 Japan Tourette Syndrome Drug Market Size YoY Growth 2015-2026
6.1.1 Japan Tourette Syndrome Drug Sales YoY Growth 2015-2026
6.1.2 Japan Tourette Syndrome Drug Revenue YoY Growth 2015-2026
6.1.3 Japan Tourette Syndrome Drug Market Share in Global Market 2015-2026
6.2 Japan Tourette Syndrome Drug Market Size by Players (International and Local Players)
6.2.1 Japan Top Tourette Syndrome Drug Players by Sales (2015-2020)
6.2.2 Japan Top Tourette Syndrome Drug Players by Revenue (2015-2020)
6.3 Japan Tourette Syndrome Drug Historic Market Review by Type (2015-2020)
6.3.1 Japan Tourette Syndrome Drug Sales Market Share by Type (2015-2020)
6.3.2 Japan Tourette Syndrome Drug Revenue Market Share by Type (2015-2020)
6.3.3 Japan Tourette Syndrome Drug Price by Type (2015-2020)
6.4 Japan Tourette Syndrome Drug Market Estimates and Forecasts by Type (2021-2026)
6.4.1 Japan Tourette Syndrome Drug Sales Forecast by Type (2021-2026)
6.4.2 Japan Tourette Syndrome Drug Revenue Forecast by Type (2021-2026)
6.4.3 Japan Tourette Syndrome Drug Price Forecast by Type (2021-2026)
6.5 Japan Tourette Syndrome Drug Historic Market Review by Application (2015-2020)
6.5.1 Japan Tourette Syndrome Drug Sales Market Share by Application (2015-2020)
6.5.2 Japan Tourette Syndrome Drug Revenue Market Share by Application (2015-2020)
6.5.3 Japan Tourette Syndrome Drug Price by Application (2015-2020)
6.6 Japan Tourette Syndrome Drug Market Estimates and Forecasts by Application (2021-2026)
6.6.1 Japan Tourette Syndrome Drug Sales Forecast by Application (2021-2026)
6.6.2 Japan Tourette Syndrome Drug Revenue Forecast by Application (2021-2026)
6.6.3 Japan Tourette Syndrome Drug Price Forecast by Application (2021-2026)
7 North America
7.1 North America Tourette Syndrome Drug Market Size YoY Growth 2015-2026
7.2 North America Tourette Syndrome Drug Market Facts & Figures by Country
7.2.1 North America Tourette Syndrome Drug Sales by Country (2015-2020)
7.2.2 North America Tourette Syndrome Drug Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Tourette Syndrome Drug Market Size YoY Growth 2015-2026
8.2 Europe Tourette Syndrome Drug Market Facts & Figures by Country
8.2.1 Europe Tourette Syndrome Drug Sales by Country
8.2.2 Europe Tourette Syndrome Drug Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Tourette Syndrome Drug Market Size YoY Growth 2015-2026
9.2 Asia Pacific Tourette Syndrome Drug Market Facts & Figures by Country
9.2.1 Asia Pacific Tourette Syndrome Drug Sales by Region (2015-2020)
9.2.2 Asia Pacific Tourette Syndrome Drug Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Tourette Syndrome Drug Market Size YoY Growth 2015-2026
10.2 Latin America Tourette Syndrome Drug Market Facts & Figures by Country
10.2.1 Latin America Tourette Syndrome Drug Sales by Country
10.2.2 Latin America Tourette Syndrome Drug Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Tourette Syndrome Drug Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Tourette Syndrome Drug Market Facts & Figures by Country
11.2.1 Middle East and Africa Tourette Syndrome Drug Sales by Country
11.2.2 Middle East and Africa Tourette Syndrome Drug Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Abide Therapeutics Inc
12.1.1 Abide Therapeutics Inc Corporation Information
12.1.2 Abide Therapeutics Inc Description and Business Overview
12.1.3 Abide Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Abide Therapeutics Inc Tourette Syndrome Drug Products Offered
12.1.5 Abide Therapeutics Inc Recent Development
12.2 Catalyst Pharmaceuticals Inc
12.2.1 Catalyst Pharmaceuticals Inc Corporation Information
12.2.2 Catalyst Pharmaceuticals Inc Description and Business Overview
12.2.3 Catalyst Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Products Offered
12.2.5 Catalyst Pharmaceuticals Inc Recent Development
12.3 Neurocrine Biosciences Inc
12.3.1 Neurocrine Biosciences Inc Corporation Information
12.3.2 Neurocrine Biosciences Inc Description and Business Overview
12.3.3 Neurocrine Biosciences Inc Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Neurocrine Biosciences Inc Tourette Syndrome Drug Products Offered
12.3.5 Neurocrine Biosciences Inc Recent Development
12.4 Psyadon Pharmaceuticals Inc
12.4.1 Psyadon Pharmaceuticals Inc Corporation Information
12.4.2 Psyadon Pharmaceuticals Inc Description and Business Overview
12.4.3 Psyadon Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Products Offered
12.4.5 Psyadon Pharmaceuticals Inc Recent Development
12.5 Reviva Pharmaceuticals Inc
12.5.1 Reviva Pharmaceuticals Inc Corporation Information
12.5.2 Reviva Pharmaceuticals Inc Description and Business Overview
12.5.3 Reviva Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Reviva Pharmaceuticals Inc Tourette Syndrome Drug Products Offered
12.5.5 Reviva Pharmaceuticals Inc Recent Development
12.6 Synchroneuron Inc
12.6.1 Synchroneuron Inc Corporation Information
12.6.2 Synchroneuron Inc Description and Business Overview
12.6.3 Synchroneuron Inc Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Synchroneuron Inc Tourette Syndrome Drug Products Offered
12.6.5 Synchroneuron Inc Recent Development
12.7 Teva Pharmaceutical Industries Ltd
12.7.1 Teva Pharmaceutical Industries Ltd Corporation Information
12.7.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
12.7.3 Teva Pharmaceutical Industries Ltd Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Products Offered
12.7.5 Teva Pharmaceutical Industries Ltd Recent Development
12.8 Therapix Biosciences Ltd
12.8.1 Therapix Biosciences Ltd Corporation Information
12.8.2 Therapix Biosciences Ltd Description and Business Overview
12.8.3 Therapix Biosciences Ltd Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Therapix Biosciences Ltd Tourette Syndrome Drug Products Offered
12.8.5 Therapix Biosciences Ltd Recent Development
12.11 Abide Therapeutics Inc
12.11.1 Abide Therapeutics Inc Corporation Information
12.11.2 Abide Therapeutics Inc Description and Business Overview
12.11.3 Abide Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Abide Therapeutics Inc Tourette Syndrome Drug Products Offered
12.11.5 Abide Therapeutics Inc Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Tourette Syndrome Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Tourette Syndrome Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of TablesTable 1. Tourette Syndrome Drug Market Segments
Table 2. Ranking of Global Top Tourette Syndrome Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Tourette Syndrome Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of AZD-5213
Table 5. Major Manufacturers of CPP-115
Table 6. Major Manufacturers of Dutetrabenazine ER
Table 7. Major Manufacturers of Ecopipam Hydrochloride
Table 8. Major Manufacturers of Others
Table 9. Global Tourette Syndrome Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Tourette Syndrome Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Tourette Syndrome Drug Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Tourette Syndrome Drug Sales Market Share by Regions (2015-2020)
Table 13. Global Tourette Syndrome Drug Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Tourette Syndrome Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 15. Global Tourette Syndrome Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 16. Global Tourette Syndrome Drug Sales Share by Manufacturers (2015-2020)
Table 17. Global Tourette Syndrome Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Tourette Syndrome Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tourette Syndrome Drug as of 2019)
Table 19. Tourette Syndrome Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Tourette Syndrome Drug Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Tourette Syndrome Drug Price (2015-2020) (USD/Pcs)
Table 22. Tourette Syndrome Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Tourette Syndrome Drug Product Type
Table 24. Date of International Manufacturers Enter into Tourette Syndrome Drug Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Tourette Syndrome Drug Sales by Type (2015-2020) (K Pcs)
Table 27. Global Tourette Syndrome Drug Sales Share by Type (2015-2020)
Table 28. Global Tourette Syndrome Drug Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Tourette Syndrome Drug Revenue Share by Type (2015-2020)
Table 30. Tourette Syndrome Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 31. Global Tourette Syndrome Drug Sales Share by Type (2021-2026)
Table 32. Global Tourette Syndrome Drug Sales by Application (2015-2020) (K Pcs)
Table 33. Global Tourette Syndrome Drug Sales Share by Application (2015-2020)
Table 34. Global Tourette Syndrome Drug Sales Share by Application (2021-2026)
Table 35. Global Tourette Syndrome Drug Sales Market Share Forecast by Application (2021-2026)
Table 36. Global Tourette Syndrome Drug Revenue by Application (2015-2020) (US$ Million)
Table 37. Global Tourette Syndrome Drug Revenue Market Share Forecast by Application (2021-2026)
Table 38. Japan Tourette Syndrome Drug Sales (K Pcs) of Key Companies (2015-2020)
Table 39. Japan Tourette Syndrome Drug Sales Share by Company (2015-2020)
Table 40. Japan Tourette Syndrome Drug Revenue (US$ Million) by Company (2015-2020)
Table 41. Japan Tourette Syndrome Drug Sales (K Pcs) by Type (2015-2020)
Table 42. Japan Tourette Syndrome Drug Sales Share by Type (2015-2020)
Table 43. Japan Tourette Syndrome Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 44. Japan Tourette Syndrome Drug Price (K Pcs) by Type (2015-2020)
Table 45. Japan Tourette Syndrome Drug Sales (K Pcs) by Type (2021-2026)
Table 46. Japan Tourette Syndrome Drug Sales Share by Type (2021-2026)
Table 47. Japan Tourette Syndrome Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 48. Japan Tourette Syndrome Drug Revenue Share by Type (2021-2026)
Table 49. Japan Tourette Syndrome Drug Price (K Pcs) by Type (2021-2026)
Table 50. Japan Tourette Syndrome Drug Sales (K Pcs) by Application (2015-2020)
Table 51. Japan Tourette Syndrome Drug Sales Share by Application (2015-2020)
Table 52. Japan Tourette Syndrome Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 53. Japan Tourette Syndrome Drug Sales (K Pcs) by Application (2021-2026)
Table 54. Japan Tourette Syndrome Drug Sales Share by Application (2021-2026)
Table 55. Japan Tourette Syndrome Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 56. Japan Tourette Syndrome Drug Revenue Share by Application (2021-2026)
Table 57. North America Tourette Syndrome Drug Sales by Country (2015-2020) (K Pcs)
Table 58. North America Tourette Syndrome Drug Sales Market Share by Country (2015-2020)
Table 59. North America Tourette Syndrome Drug Revenue by Country (2015-2020) (US$ Million)
Table 60. North America Tourette Syndrome Drug Revenue Market Share by Country (2015-2020)
Table 61. Europe Tourette Syndrome Drug Sales by Country (2015-2020) (K Pcs)
Table 62. Europe Tourette Syndrome Drug Sales Market Share by Country (2015-2020)
Table 63. Europe Tourette Syndrome Drug Revenue by Country (2015-2020) (US$ Million)
Table 64. Europe Tourette Syndrome Drug Revenue Market Share by Country (2015-2020)
Table 65. Asia Pacific Tourette Syndrome Drug Sales by Region (2015-2020) (K Pcs)
Table 66. Asia Pacific Tourette Syndrome Drug Sales Market Share by Region (2015-2020)
Table 67. Asia Pacific Tourette Syndrome Drug Revenue by Region (2015-2020) (US$ Million)
Table 68. Asia Pacific Tourette Syndrome Drug Revenue Market Share by Region (2015-2020)
Table 69. Latin America Tourette Syndrome Drug Sales by Country (2015-2020) (K Pcs)
Table 70. Latin America Tourette Syndrome Drug Sales Market Share by Country (2015-2020)
Table 71. Latin Americaa Tourette Syndrome Drug Revenue by Country (2015-2020) (US$ Million)
Table 72. Latin America Tourette Syndrome Drug Revenue Market Share by Country (2015-2020)
Table 73. Middle East and Africa Tourette Syndrome Drug Sales by Country (2015-2020) (K Pcs)
Table 74. Middle East and Africa Tourette Syndrome Drug Sales Market Share by Country (2015-2020)
Table 75. Middle East and Africa Tourette Syndrome Drug Revenue by Country (2015-2020) (US$ Million)
Table 76. Middle East and Africa Tourette Syndrome Drug Revenue Market Share by Country (2015-2020)
Table 77. Abide Therapeutics Inc Corporation Information
Table 78. Abide Therapeutics Inc Description and Business Overview
Table 79. Abide Therapeutics Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Abide Therapeutics Inc Tourette Syndrome Drug Product
Table 81. Abide Therapeutics Inc Recent Development
Table 82. Catalyst Pharmaceuticals Inc Corporation Information
Table 83. Catalyst Pharmaceuticals Inc Description and Business Overview
Table 84. Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Catalyst Pharmaceuticals Inc Product
Table 86. Catalyst Pharmaceuticals Inc Recent Development
Table 87. Neurocrine Biosciences Inc Corporation Information
Table 88. Neurocrine Biosciences Inc Description and Business Overview
Table 89. Neurocrine Biosciences Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Neurocrine Biosciences Inc Product
Table 91. Neurocrine Biosciences Inc Recent Development
Table 92. Psyadon Pharmaceuticals Inc Corporation Information
Table 93. Psyadon Pharmaceuticals Inc Description and Business Overview
Table 94. Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Psyadon Pharmaceuticals Inc Product
Table 96. Psyadon Pharmaceuticals Inc Recent Development
Table 97. Reviva Pharmaceuticals Inc Corporation Information
Table 98. Reviva Pharmaceuticals Inc Description and Business Overview
Table 99. Reviva Pharmaceuticals Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Reviva Pharmaceuticals Inc Product
Table 101. Reviva Pharmaceuticals Inc Recent Development
Table 102. Synchroneuron Inc Corporation Information
Table 103. Synchroneuron Inc Description and Business Overview
Table 104. Synchroneuron Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. Synchroneuron Inc Product
Table 106. Synchroneuron Inc Recent Development
Table 107. Teva Pharmaceutical Industries Ltd Corporation Information
Table 108. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 109. Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. Teva Pharmaceutical Industries Ltd Product
Table 111. Teva Pharmaceutical Industries Ltd Recent Development
Table 112. Therapix Biosciences Ltd Corporation Information
Table 113. Therapix Biosciences Ltd Description and Business Overview
Table 114. Therapix Biosciences Ltd Tourette Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 115. Therapix Biosciences Ltd Product
Table 116. Therapix Biosciences Ltd Recent Development
Table 117. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 118. Key Challenges
Table 119. Market Risks
Table 120. Main Points Interviewed from Key Tourette Syndrome Drug Players
Table 121. Tourette Syndrome Drug Customers List
Table 122. Tourette Syndrome Drug Distributors List
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of FiguresFigure 1. Tourette Syndrome Drug Product Picture
Figure 2. Global Tourette Syndrome Drug Sales Market Share by Type in 2020 & 2026
Figure 3. AZD-5213 Product Picture
Figure 4. CPP-115 Product Picture
Figure 5. Dutetrabenazine ER Product Picture
Figure 6. Ecopipam Hydrochloride Product Picture
Figure 7. Others Product Picture
Figure 8. Global Tourette Syndrome Drug Sales Market Share by Application in 2020 & 2026
Figure 9. Research Center
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Others
Figure 13. Tourette Syndrome Drug Report Years Considered
Figure 14. Global Tourette Syndrome Drug Market Size 2015-2026 (US$ Million)
Figure 15. Global Tourette Syndrome Drug Sales 2015-2026 (K Pcs)
Figure 16. Global Tourette Syndrome Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Tourette Syndrome Drug Sales Market Share by Region (2015-2020)
Figure 18. Global Tourette Syndrome Drug Sales Market Share by Region in 2019
Figure 19. Global Tourette Syndrome Drug Revenue Market Share by Region (2015-2020)
Figure 20. Global Tourette Syndrome Drug Revenue Market Share by Region in 2019
Figure 21. Global Tourette Syndrome Drug Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Tourette Syndrome Drug Revenue in 2019
Figure 23. Tourette Syndrome Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Tourette Syndrome Drug Sales Market Share by Type (2015-2020)
Figure 25. Global Tourette Syndrome Drug Sales Market Share by Type in 2019
Figure 26. Global Tourette Syndrome Drug Revenue Market Share by Type (2015-2020)
Figure 27. Global Tourette Syndrome Drug Revenue Market Share by Type in 2019
Figure 28. Global Tourette Syndrome Drug Market Share by Price Range (2015-2020)
Figure 29. Global Tourette Syndrome Drug Sales Market Share by Application (2015-2020)
Figure 30. Global Tourette Syndrome Drug Sales Market Share by Application in 2019
Figure 31. Global Tourette Syndrome Drug Revenue Market Share by Application (2015-2020)
Figure 32. Global Tourette Syndrome Drug Revenue Market Share by Application in 2019
Figure 33. Japan Tourette Syndrome Drug Sales Growth Rate 2015-2026 (K Pcs)
Figure 34. Japan Tourette Syndrome Drug Revenue Growth Rate 2015-2026 (US$ Million)
Figure 35. Japan Tourette Syndrome Drug Market Share in Global Market 2015-2026
Figure 36. Japan 5 and 10 Largest Tourette Syndrome Drug Players Market Share by Revenue in Tourette Syndrome Drug in 2019
Figure 37. Japan Tourette Syndrome Drug Revenue Share by Type (2015-2020)
Figure 38. Japan Tourette Syndrome Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 39. Japan Tourette Syndrome Drug Revenue Share by Application (2015-2020)
Figure 40. Japan Tourette Syndrome Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 41. North America Tourette Syndrome Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 42. North America Tourette Syndrome Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. North America Tourette Syndrome Drug Sales Market Share by Country in 2019
Figure 44. North America Tourette Syndrome Drug Revenue Market Share by Country in 2019
Figure 45. U.S. Tourette Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 46. U.S. Tourette Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Canada Tourette Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. Canada Tourette Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Europe Tourette Syndrome Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 50. Europe Tourette Syndrome Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 51. Europe Tourette Syndrome Drug Sales Market Share by Country in 2019
Figure 52. Europe Tourette Syndrome Drug Revenue Market Share by Country in 2019
Figure 53. Germany Tourette Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Germany Tourette Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. France Tourette Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. France Tourette Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. U.K. Tourette Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 58. U.K. Tourette Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Italy Tourette Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 60. Italy Tourette Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Russia Tourette Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 62. Russia Tourette Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Asia Pacific Tourette Syndrome Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 64. Asia Pacific Tourette Syndrome Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 65. Asia Pacific Tourette Syndrome Drug Sales Market Share by Region in 2019
Figure 66. Asia Pacific Tourette Syndrome Drug Revenue Market Share by Region in 2019
Figure 67. China Tourette Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. China Tourette Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Japan Tourette Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. Japan Tourette Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. South Korea Tourette Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. South Korea Tourette Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. India Tourette Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. India Tourette Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Australia Tourette Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Australia Tourette Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Taiwan Tourette Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Taiwan Tourette Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Indonesia Tourette Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Indonesia Tourette Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Thailand Tourette Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Thailand Tourette Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Malaysia Tourette Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Malaysia Tourette Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Philippines Tourette Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 86. Philippines Tourette Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Vietnam Tourette Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 88. Vietnam Tourette Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Latin America Tourette Syndrome Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 90. Latin America Tourette Syndrome Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 91. Latin America Tourette Syndrome Drug Sales Market Share by Country in 2019
Figure 92. Latin America Tourette Syndrome Drug Revenue Market Share by Country in 2019
Figure 93. Mexico Tourette Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Mexico Tourette Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Brazil Tourette Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Brazil Tourette Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Argentina Tourette Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 98. Argentina Tourette Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 99. Middle East and Africa Tourette Syndrome Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 100. Middle East and Africa Tourette Syndrome Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Tourette Syndrome Drug Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Tourette Syndrome Drug Revenue Market Share by Country in 2019
Figure 103. Turkey Tourette Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Turkey Tourette Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Tourette Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Saudi Arabia Tourette Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Tourette Syndrome Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. U.A.E Tourette Syndrome Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Porter's Five Forces Analysis
Figure 110. Tourette Syndrome Drug Value Chain
Figure 111. Channels of Distribution
Figure 112. Distributors Profiles
Figure 113. Bottom-up and Top-down Approaches for This Report
Figure 114. Data Triangulation
Figure 115. Key Executives Interviewed